Montas-L is a pediatric oral liquid formulation, containing a combination of levocetirizine (2.5mg/5ml) and montelukast (4mg/5ml), indicated for the treatment of allergic rhinitis, urticaria, and bronchial asthma in pediatric patients. This fixed-dose combination product provides a convenient and effective way to manage symptoms of allergy and asthma in children, reducing the need for multiple medications. Levocetirizine, an antihistamine, helps to relieve symptoms of allergic rhinitis, such as sneezing, runny nose, and itchy eyes, while montelukast, a leukotriene receptor antagonist, helps to prevent bronchospasm and reduce symptoms of asthma, such as wheezing and coughing. Montas-L is available in a palatable, orange-flavored liquid formulation, making it easy to administer to pediatric patients. The recommended dose is 2.5mL (1 teaspoon) twice daily, or as directed by a healthcare provider. Montas-L is a valuable treatment option for pediatric patients with allergic rhinitis, urticaria, and bronchial asthma, offering a convenient and effective way to manage symptoms and improve quality of life.